Inhibiting the NF-[kappa]B pathway enhances the antitumor effect of cabazitaxel by downregulating Bc...
Inhibiting the NF-[kappa]B pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer
About this item
Full title
Author / Creator
Publisher
Spandidos Publications
Journal title
Language
English
Formats
Publication information
Publisher
Spandidos Publications
Subjects
More information
Scope and Contents
Contents
Optimizing the currently available treatment options for pancreatic cancer (PC) is a priority. Cabazitaxel (CTX), a semisynthetic taxane, is mainly used for treating patients with PC who are resistant to paclitaxel (PTX) or docetaxel, due its poor affinity for P-glycoprotein. However, there are only a few studies demonstrating the effect of CTX on...
Alternative Titles
Full title
Inhibiting the NF-[kappa]B pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A628079227
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A628079227
Other Identifiers
ISSN
1019-6439
DOI
10.3892/ijo.2020.5053
